echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Qilu has another class of new drugs to attack the first oral dissolved membrane will be approved Qilu and another class of new drugs to attack the first oral soluble membrane will be approved

    Qilu has another class of new drugs to attack the first oral dissolved membrane will be approved Qilu and another class of new drugs to attack the first oral soluble membrane will be approved

    • Last Update: 2021-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 9, Qilu Pharmaceutical's class 1 new drug injection QLS31901 clinical application was accepted by CDE contractor, acceptance number CXSL2100012.
    injection QLS31901 is the first new class 1 drug to be declared clinically by Qilu Pharmaceuticals in 2021.
    recent years, Qilu Pharmaceuticals in the field of innovative drugs, in 2020 a total of 4 new class 1 drugs submitted clinical applications, all therapeutic biological products.
    2020 Qilu Pharmaceuticals declared clinical class 1 new drug Class 2 modified new drug Qilu Pharmaceutical has also begun to lay out, is about to enter the harvest period.
    meters of intranet data show that Qilu Pharmaceuticals has 5 new class 2.2 drugs submitted for listing, respectively, Tadara non-oral dissolved membrane, O nitrogen flat mouth solution film, Mengluste sodium mouth solution membrane, hydrochloric acid methicillin oral dissolution membrane, alium oral dissolution membrane, are oral solution film.
    , the registration status of the O nitrogen flat-mouth soluble film has been changed to "in the approval", is expected to be approved for listing recently, becoming the company's first oral soluble film agent.
    Qilu Pharmaceuticals O nitrogen flat mouth dissolved membrane listing application Source: Mi net one-click search O nitrogen flat is mainly used for the treatment of schizophrenia, Minanet data show that in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal O nitrogen flat sales of more than 4 billion yuan.
    At present, the domestic market of O nitrogen flat products have O nitrogen flat tablets, O nitrogen flat mouth collapse tablets and O nitrogen flat mouth dissolved membrane, O nitrogen flat mouth dissolved membrane only Howson Pharmaceuticals was approved, Qilu Pharmaceuticals is expected to become the second domestic.
    source: Minet database, CDE
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.